News

The Society for Immunotherapy of Cancer (SITC) is the world's leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and ...
Is the long-awaited cure for cancer right around the corner? While the insidious disease continues to plague millions ...
Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...
Artificial intelligence (AI) technologies and machine learning (ML) algorithms are witnessing tremendous growth in immunology ...
Media: Jeffrey Krasner Slowey McManus Communications jkrasner@sloweymcmanus.com +1 (617) 840-9806 Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to ...
As part of a $93 million grant package, the Cancer Prevention and Research Institute of Texas, known for funding ...
PharmaJet needle-free technology can improve DNA vaccine delivery 1 and has been successfully adopted into multiple cancer vaccine development programs. Partner study data shows how PharmaJet ...
Society for Immunotherapy of Cancer (SITC) 2023 poster. 3 Paston, et al (2024). A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced ...